Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors

New imidazo[1,2-a]quinoxaline derivatives have been synthesised by condensation of an appropriate alpha-aminoalcohol with a quinoxaline followed by intramolecular cyclisation and nucleophilic substitutions. Their phosphodiesterase inhibitory activities have been assessed on a preparation of the PDE4...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2004-03, Vol.12 (5), p.1129-1139
Hauptverfasser: DELEUZE-MASQUBFA, Carine, GEREBTZOFF, Grégori, SUBRA, Guy, FABREGUETTES, Jean-Roch, OVENS, Annabel, CARRAZ, Maëlle, STRUB, Marie-Paule, BOMPART, Jacques, GEORGE, Pascal, BONNET, Pierre-Antoine
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1139
container_issue 5
container_start_page 1129
container_title Bioorganic & medicinal chemistry
container_volume 12
creator DELEUZE-MASQUBFA, Carine
GEREBTZOFF, Grégori
SUBRA, Guy
FABREGUETTES, Jean-Roch
OVENS, Annabel
CARRAZ, Maëlle
STRUB, Marie-Paule
BOMPART, Jacques
GEORGE, Pascal
BONNET, Pierre-Antoine
description New imidazo[1,2-a]quinoxaline derivatives have been synthesised by condensation of an appropriate alpha-aminoalcohol with a quinoxaline followed by intramolecular cyclisation and nucleophilic substitutions. Their phosphodiesterase inhibitory activities have been assessed on a preparation of the PDE4 isoform purified from a human alveolar epithelial cell line (A549). These studies showed potent inhibitory properties that emphasize the importance of a methyl amino group at position 4 and a weakly hindered group at position 1.
doi_str_mv 10.1016/j.bmc.2003.11.034
format Article
fullrecord <record><control><sourceid>pubmed_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04741189v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14980625</sourcerecordid><originalsourceid>FETCH-LOGICAL-c363t-a66d348527dff11d36f78980dcc49875b5619646521ebf2b10e45729d6e200ab3</originalsourceid><addsrcrecordid>eNpFkE1Lw0AQhhdRbK3-AC-yFw-CiTv7leQobbViQQ96Elk2ycZuSTY12xbrr3dLiz0NMzzvMPMgdAkkBgLybh7nTRFTQlgMEBPGj1AfuOQRYxkcoz7JZBqRNJM9dOb9nBBCeQanqAc8S4mkoo-eR8bbL4e1K7HfuOUstB63FXbt2tTYNrbUv-0H3NJIf36vrGt_dG2d8Vh7_Doac2zdzOZ22Xb-HJ1UuvbmYl8H6P1h_DacRNOXx6fh_TQqmGTLSEtZMp4KmpRVBVAyWSVpuKcsinBWInIhIZNcCgomr2gOxHCR0KyUJryqczZAN7u9M12rRWcb3W1Uq62a3E_VdkZ4wgHSbA2BhR1bdK33nan-A0DUVqKaqyBRbSUqABUkhszVLrNY5Y0pD4m9tQBc7wHtC11XnXaF9QdOCMIoJewPhfJ4rA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>DELEUZE-MASQUBFA, Carine ; GEREBTZOFF, Grégori ; SUBRA, Guy ; FABREGUETTES, Jean-Roch ; OVENS, Annabel ; CARRAZ, Maëlle ; STRUB, Marie-Paule ; BOMPART, Jacques ; GEORGE, Pascal ; BONNET, Pierre-Antoine</creator><creatorcontrib>DELEUZE-MASQUBFA, Carine ; GEREBTZOFF, Grégori ; SUBRA, Guy ; FABREGUETTES, Jean-Roch ; OVENS, Annabel ; CARRAZ, Maëlle ; STRUB, Marie-Paule ; BOMPART, Jacques ; GEORGE, Pascal ; BONNET, Pierre-Antoine</creatorcontrib><description>New imidazo[1,2-a]quinoxaline derivatives have been synthesised by condensation of an appropriate alpha-aminoalcohol with a quinoxaline followed by intramolecular cyclisation and nucleophilic substitutions. Their phosphodiesterase inhibitory activities have been assessed on a preparation of the PDE4 isoform purified from a human alveolar epithelial cell line (A549). These studies showed potent inhibitory properties that emphasize the importance of a methyl amino group at position 4 and a weakly hindered group at position 1.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2003.11.034</identifier><identifier>PMID: 14980625</identifier><language>eng</language><publisher>Oxford: Elsevier Science</publisher><subject>3',5'-Cyclic-AMP Phosphodiesterases - antagonists &amp; inhibitors ; 3',5'-Cyclic-AMP Phosphodiesterases - isolation &amp; purification ; Biological and medical sciences ; Cell Line ; Chemical Sciences ; Cyclic Nucleotide Phosphodiesterases, Type 4 ; Drug Design ; Epithelial Cells - enzymology ; Humans ; Inflammation - prevention &amp; control ; Inhibitory Concentration 50 ; Lung - cytology ; Medical sciences ; Medicinal Chemistry ; Pharmacology. Drug treatments ; Quinoxalines - chemical synthesis ; Quinoxalines - pharmacology ; Respiratory system ; Structure-Activity Relationship</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2004-03, Vol.12 (5), p.1129-1139</ispartof><rights>2004 INIST-CNRS</rights><rights>Copyright</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c363t-a66d348527dff11d36f78980dcc49875b5619646521ebf2b10e45729d6e200ab3</citedby><cites>FETCH-LOGICAL-c363t-a66d348527dff11d36f78980dcc49875b5619646521ebf2b10e45729d6e200ab3</cites><orcidid>0000-0001-8579-4150 ; 0000-0002-4086-5178 ; 0000-0001-8538-1567</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15503220$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14980625$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04741189$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>DELEUZE-MASQUBFA, Carine</creatorcontrib><creatorcontrib>GEREBTZOFF, Grégori</creatorcontrib><creatorcontrib>SUBRA, Guy</creatorcontrib><creatorcontrib>FABREGUETTES, Jean-Roch</creatorcontrib><creatorcontrib>OVENS, Annabel</creatorcontrib><creatorcontrib>CARRAZ, Maëlle</creatorcontrib><creatorcontrib>STRUB, Marie-Paule</creatorcontrib><creatorcontrib>BOMPART, Jacques</creatorcontrib><creatorcontrib>GEORGE, Pascal</creatorcontrib><creatorcontrib>BONNET, Pierre-Antoine</creatorcontrib><title>Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>New imidazo[1,2-a]quinoxaline derivatives have been synthesised by condensation of an appropriate alpha-aminoalcohol with a quinoxaline followed by intramolecular cyclisation and nucleophilic substitutions. Their phosphodiesterase inhibitory activities have been assessed on a preparation of the PDE4 isoform purified from a human alveolar epithelial cell line (A549). These studies showed potent inhibitory properties that emphasize the importance of a methyl amino group at position 4 and a weakly hindered group at position 1.</description><subject>3',5'-Cyclic-AMP Phosphodiesterases - antagonists &amp; inhibitors</subject><subject>3',5'-Cyclic-AMP Phosphodiesterases - isolation &amp; purification</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Chemical Sciences</subject><subject>Cyclic Nucleotide Phosphodiesterases, Type 4</subject><subject>Drug Design</subject><subject>Epithelial Cells - enzymology</subject><subject>Humans</subject><subject>Inflammation - prevention &amp; control</subject><subject>Inhibitory Concentration 50</subject><subject>Lung - cytology</subject><subject>Medical sciences</subject><subject>Medicinal Chemistry</subject><subject>Pharmacology. Drug treatments</subject><subject>Quinoxalines - chemical synthesis</subject><subject>Quinoxalines - pharmacology</subject><subject>Respiratory system</subject><subject>Structure-Activity Relationship</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1Lw0AQhhdRbK3-AC-yFw-CiTv7leQobbViQQ96Elk2ycZuSTY12xbrr3dLiz0NMzzvMPMgdAkkBgLybh7nTRFTQlgMEBPGj1AfuOQRYxkcoz7JZBqRNJM9dOb9nBBCeQanqAc8S4mkoo-eR8bbL4e1K7HfuOUstB63FXbt2tTYNrbUv-0H3NJIf36vrGt_dG2d8Vh7_Doac2zdzOZ22Xb-HJ1UuvbmYl8H6P1h_DacRNOXx6fh_TQqmGTLSEtZMp4KmpRVBVAyWSVpuKcsinBWInIhIZNcCgomr2gOxHCR0KyUJryqczZAN7u9M12rRWcb3W1Uq62a3E_VdkZ4wgHSbA2BhR1bdK33nan-A0DUVqKaqyBRbSUqABUkhszVLrNY5Y0pD4m9tQBc7wHtC11XnXaF9QdOCMIoJewPhfJ4rA</recordid><startdate>20040301</startdate><enddate>20040301</enddate><creator>DELEUZE-MASQUBFA, Carine</creator><creator>GEREBTZOFF, Grégori</creator><creator>SUBRA, Guy</creator><creator>FABREGUETTES, Jean-Roch</creator><creator>OVENS, Annabel</creator><creator>CARRAZ, Maëlle</creator><creator>STRUB, Marie-Paule</creator><creator>BOMPART, Jacques</creator><creator>GEORGE, Pascal</creator><creator>BONNET, Pierre-Antoine</creator><general>Elsevier Science</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-8579-4150</orcidid><orcidid>https://orcid.org/0000-0002-4086-5178</orcidid><orcidid>https://orcid.org/0000-0001-8538-1567</orcidid></search><sort><creationdate>20040301</creationdate><title>Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors</title><author>DELEUZE-MASQUBFA, Carine ; GEREBTZOFF, Grégori ; SUBRA, Guy ; FABREGUETTES, Jean-Roch ; OVENS, Annabel ; CARRAZ, Maëlle ; STRUB, Marie-Paule ; BOMPART, Jacques ; GEORGE, Pascal ; BONNET, Pierre-Antoine</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c363t-a66d348527dff11d36f78980dcc49875b5619646521ebf2b10e45729d6e200ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>3',5'-Cyclic-AMP Phosphodiesterases - antagonists &amp; inhibitors</topic><topic>3',5'-Cyclic-AMP Phosphodiesterases - isolation &amp; purification</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Chemical Sciences</topic><topic>Cyclic Nucleotide Phosphodiesterases, Type 4</topic><topic>Drug Design</topic><topic>Epithelial Cells - enzymology</topic><topic>Humans</topic><topic>Inflammation - prevention &amp; control</topic><topic>Inhibitory Concentration 50</topic><topic>Lung - cytology</topic><topic>Medical sciences</topic><topic>Medicinal Chemistry</topic><topic>Pharmacology. Drug treatments</topic><topic>Quinoxalines - chemical synthesis</topic><topic>Quinoxalines - pharmacology</topic><topic>Respiratory system</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DELEUZE-MASQUBFA, Carine</creatorcontrib><creatorcontrib>GEREBTZOFF, Grégori</creatorcontrib><creatorcontrib>SUBRA, Guy</creatorcontrib><creatorcontrib>FABREGUETTES, Jean-Roch</creatorcontrib><creatorcontrib>OVENS, Annabel</creatorcontrib><creatorcontrib>CARRAZ, Maëlle</creatorcontrib><creatorcontrib>STRUB, Marie-Paule</creatorcontrib><creatorcontrib>BOMPART, Jacques</creatorcontrib><creatorcontrib>GEORGE, Pascal</creatorcontrib><creatorcontrib>BONNET, Pierre-Antoine</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DELEUZE-MASQUBFA, Carine</au><au>GEREBTZOFF, Grégori</au><au>SUBRA, Guy</au><au>FABREGUETTES, Jean-Roch</au><au>OVENS, Annabel</au><au>CARRAZ, Maëlle</au><au>STRUB, Marie-Paule</au><au>BOMPART, Jacques</au><au>GEORGE, Pascal</au><au>BONNET, Pierre-Antoine</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2004-03-01</date><risdate>2004</risdate><volume>12</volume><issue>5</issue><spage>1129</spage><epage>1139</epage><pages>1129-1139</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>New imidazo[1,2-a]quinoxaline derivatives have been synthesised by condensation of an appropriate alpha-aminoalcohol with a quinoxaline followed by intramolecular cyclisation and nucleophilic substitutions. Their phosphodiesterase inhibitory activities have been assessed on a preparation of the PDE4 isoform purified from a human alveolar epithelial cell line (A549). These studies showed potent inhibitory properties that emphasize the importance of a methyl amino group at position 4 and a weakly hindered group at position 1.</abstract><cop>Oxford</cop><pub>Elsevier Science</pub><pmid>14980625</pmid><doi>10.1016/j.bmc.2003.11.034</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-8579-4150</orcidid><orcidid>https://orcid.org/0000-0002-4086-5178</orcidid><orcidid>https://orcid.org/0000-0001-8538-1567</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2004-03, Vol.12 (5), p.1129-1139
issn 0968-0896
1464-3391
language eng
recordid cdi_hal_primary_oai_HAL_hal_04741189v1
source MEDLINE; Elsevier ScienceDirect Journals
subjects 3',5'-Cyclic-AMP Phosphodiesterases - antagonists & inhibitors
3',5'-Cyclic-AMP Phosphodiesterases - isolation & purification
Biological and medical sciences
Cell Line
Chemical Sciences
Cyclic Nucleotide Phosphodiesterases, Type 4
Drug Design
Epithelial Cells - enzymology
Humans
Inflammation - prevention & control
Inhibitory Concentration 50
Lung - cytology
Medical sciences
Medicinal Chemistry
Pharmacology. Drug treatments
Quinoxalines - chemical synthesis
Quinoxalines - pharmacology
Respiratory system
Structure-Activity Relationship
title Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T03%3A43%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design%20and%20synthesis%20of%20novel%20imidazo%5B1,2-a%5Dquinoxalines%20as%20PDE4%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=DELEUZE-MASQUBFA,%20Carine&rft.date=2004-03-01&rft.volume=12&rft.issue=5&rft.spage=1129&rft.epage=1139&rft.pages=1129-1139&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2003.11.034&rft_dat=%3Cpubmed_hal_p%3E14980625%3C/pubmed_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/14980625&rfr_iscdi=true